One expert estimates that the use of molecular diagnostics in oncology has more than doubled in the last 5 years—but scientific, technical, regulatory and economic issues all will impact the spread of these tests.

Practical considerations slow the adoption of tests for personalized cancer care

©2011 American Association for Cancer Research.
2011